To further evaluate our earlier findings on the feasibility and effectiveness of home-based management of neonatal sepsis by analysing 7 years data (1996 to 2003) from the field trial in Gadchiroli, India.
INTRODUCTION
Neonatal infections are a major cause of morbidity and mortality worldwide. The World Health Organisation estimates that, globally, 32% of the estimated four million neonatal deaths each year are caused by infections, including sepsis, pneumonia, diarrhea, and tetanus. 1 Another global review of neonatal infections estimated that annually there are approximately 29 million neonatal infections (including 800,000 cases of sepsis and 130,000 cases of meningitis) and as many as 1.5 million neonatal deaths due to infections. 2 In Gadchiroli, India, we have studied clinical sepsis among home-based neonates in 39 villages since 1995. In our studies, the term 'sepsis' includes neonatal sepsis, pneumonia, and meningitis. In a cohort of 763 neonates prospectively observed in 1995 to 1996, we estimated the incidence of clinically suspected sepsis to be 17.0 % and the case fatality (CF) without interventions to be 18.5%. 3, 4 Moreover, sepsis was the primary cause in 52.5% of neonatal deaths. 5, 6 The management of sepsis by trained village heath workers (VHWs) is one of the interventions in the home-based neonatal care package in the field trial in Gadchiroli. 5 Promising early data (1996 to 1998) on 71 cases suggested that VHWs could identify and manage neonates with suspected sepsis in the home setting, resulting in improved survival. This initial experience raised the possibility that managing neonatal infections in the community may be an intervention with broad applicability. Since then, three new field trials of community-based management of sepsis in neonates have been started in India and Bangladesh.
We have continued the home-based interventions and monitoring in the Gadchiroli field area to date. In the current paper, we present the data and experience up to March 2003.
RESEARCH QUESTIONS
To evaluate the feasibility and effectiveness of home-based management of neonates with suspected sepsis, we asked seven questions: 
METHODS

Data Sources
We have previously described the area, study design, methods of data collection, and the interventions in the field trial. 5, 7 The data reviewed in this paper come from six sources:
(1) Maternal and neonatal health records completed by the VHWs during home visits. The date of onset of the last menstrual period was recorded from the history given by the woman at the time of registering her pregnancy, usually in the fourth month of pregnancy. The period of gestation was estimated at birth from this information. The birth weight was recorded by VHWs, usually within 6 hours after birth, by weighing the baby using a 0 to 5 kg spring balance (Salter In an earlier study, we found that data recorded by VHWs showed 92% agreement with parallel observations by a visiting physician. 3 Four possible complications of antibiotic injections were specifically looked for: (i) cellulitis or abscess at the site of injection, (ii) hemorrhage at the site of injection, (iii) decreased tone and movement in the limb suggesting nerve injury, (iv) skin rash indicating possible drug allergy. (3) Records of the supplies provided to VHWs. (4) The field diaries maintained by the field supervisors. These provided additional clinical data, as well as the difficulties faced and community reactions.
(5) Meetings with VHWs, supervisors, and physician every 2 months to discuss qualitative experiences and the difficulties experienced by VHWs. (6) Vital statistics surveillance in the study area, conducted by independent field workers and supervisors. Previously, we reported that 98% of births and child deaths were recorded by this system. 5 Recorded data are entered onto the computer within 30 days of collection and analyzed every 6 months. A computer algorithm was written to identify cases of sepsis using the diagnostic criteria and the data in the neonatal records and sepsis monitoring forms. The incidence of sepsis was estimated from these diagnosed cases. The proportion of neonates with sepsis correctly diagnosed by VHWs (true positive), diagnoses missed by the VHW (false negative), or over-diagnosed (false positive) were estimated by comparing the VHW's sepsis diagnosis and treatment records with the cases identified by the computer algorithm of sepsis. The total live births and neonatal deaths were provided by the vital statistics surveillance. We calculated the number of vitamin K injections given from the newborn forms, and the number of gentamicin injections from the sepsis treatment forms. These were regularly matched with the supplies given to VHWs to ensure the proper use of medicines and syringes.
Home-based interventions in the field trial in Gadchiroli have been previously reported. 5 Interventions relevant to sepsis management are presented in Box 2.
The Choice of Antibiotics
In the absence of bacterial culture and sensitivity reports, the antibiotics recommended for treating neonatal sepsis in developed countries are parenteral ampicillin and gentamicin. 8, 9 This combination covers a broad spectrum of organisms that cause neonatal sepsis, including Escherichia coli, Klebsiella, Streptococcus pneumoniae, Staphylococcus aureus, Group B Streptococcus and Hemophilus influenzae. In the absence of community-based data on the organisms causing neonatal sepsis in Gadchiroli, we used our community-based data regarding organisms colonizing the maternal reproductive tract of rural women in Gadchiroli. 10, 11 Of 280 maternal genital bacterial isolates, 93% were sensitive to co-trimoxazole, 95% to gentamicin, and 100% were sensitive to at least one of these.
For this study we chose to use parenteral gentamicin and oral co-trimoxazole (rather than parenteral ampicillin). We have previously studied the use of co-trimoxazole for pneumonia in children, including neonates, in this area 11 and reported a 40% reduction in pneumonia-specific mortality rate in neonates in the intervention area. Moreover, co-trimoxazole can be administered orally. Thus, based on this background and the recommendations of the advisory group of pediatricians, we chose injection gentamicin and oral co-trimoxazole as the antibiotic combination for treating suspected sepsis. The dose and the duration of antibiotic administration are described in Table 9 .
Syringe and Needle
Gentamicin is available in India in only one strength, 40 mg/ml. As neonates in our trial needed very small doses (5 or 7.5 mg twice a day), we used disposable insulin syringes and needles to enable VHWs to accurately dispense the proper dose. These syringes, marked for insulin at 40 U/ml, match exactly with the available 
K
VHWs were trained to diagnose sepsis if two or more of the signs/ symptoms were simultaneously present in the baby.
For neonates diagnosed with clinical sepsis, the VHW: 1. Informed parents of the illness, and the threat to newborn's life. 2. Advised parents to immediately take the baby to hospital, then the VHW offered treatment at home and obtained a written informed consent form. 3. Maintained normal body temperature and breastmilk feeding of the baby.
Administered antibiotics:
J Gentamicin injected intramuscularly in the antero-lateral aspect of baby's thigh. The dose of gentamicin was 10 mg per day for 10 days for pre-term babies with birth weight <2500 g, and 15 mg per day for 7 days to full-term babies or to those with birth weight Z2500 g. Gentamicin was given divided in two daily doses, except for a period (June 1998 to January 2001) during which it was given in once a day dosing.
J Syrup co-trimoxazole (sulphamethoxazole 200 mg+trimethoprim 40 mg per 5 ml) 1.25 ml twice a day for 7 days. 5. Made daily home visits to baby under treatment to administer antibiotics and record progress. strength of gentamicin, and allow precise measurement of the gentamicin dose. The small needle available with the insulin syringe ensures that the needle does not penetrate too far into neonate's thigh. Disposable syringes and needle reduce the risk of infection.
VHWs were asked to store all used syringes without washing them in a plastic box, and return these to the field supervisor. An account of syringes supplied and returned was maintained and checked with the number of neonates treated to prevent any unaccounted use to give unnecessary injections by VHWs.
Training and Supervision
We trained VHWs in stages. In 1995 they were trained to take history, examine a mother and newborn, and record data. They monitored the neonates in their village during one year (April 95 to March 96). In May 1996, we taught VHWs to give intramuscular vitamin K. When they had given 10 injections to newborns in their village in the presence of the field supervisor without any error, they were certified to give injection vitamin K independently on the day of birth. In July -August 1996, we trained VHWs to diagnose and treat sepsis (Tables 8 and 9 ). They were repeatedly assessed by simulated exercises and retrained, until performance was deemed satisfactory. Beginning in September 1996, we permitted them to diagnose and treat sepsis as per guidelines. Communities were informed of this new intervention, and mothers and families were given health education to recognize danger signs and seek care from the VHW. As a VHW was likely to diagnose and treat a case of sepsis only once or twice each year, continued training and drills with assessment were made in the supervisory visits and in the bimonthly review meetings to help retain her skills. Close field supervision of VHWs, continued training, education of community and families about sepsis management, and regular uninterrupted supplies were maintained.
Communication with Medical Community
We informed and explained this intervention by visiting local private doctors. Senior pediatricians, neonatologists, and public health professionals of national standing were involved in this trial as members of an external advisory committee which met at the field site in 1995, 1996, and 1998. The committee reviewed our data, advised us about interventions, assessed the quality of training for VHWs, and gave ethical clearance. 5, 7 The study director (AB) presented the findings of the trial at the annual national conferences of the Indian Academy of Pediatrics (IAP) and the National Neonatology Forum (NNF) of India. A national workshop was jointly organized by the IAP, NNF, UNICEF, and SEARCH in 1999 at the project headquarters to study the findings of the trial and discuss its significance for national policy. A consensus statement was issued on this approach by the national workshop. 12 The second national workshop was organized on 31 March 2003 at the project headquarters. 13 Consent and ethical clearance. All neonates with suspected sepsis were advised hospitalization. If parents did not agree to it, a written consent from all families was taken before treatment at home. An external advisory committee gave ethical clearance.
RESULTS
A total of 5796 live births were recorded in 39 intervention villages from April 1996 to March 2003. Of these, 169 neonates died (neonatal mortality rate (NMR) 29.1/1000 live births). Additionally, 123 neonates from other areas were transiently in the intervention villages and were monitored by VHWs. Thus, in total 5919 neonates were present during 1996 to 2003 in the intervention villages. VHWs visited 5510 of these neonates, giving a service coverage of 93.1%.
From September 1996, when sepsis management was started, to March 2003, 5268 neonates were visited by the VHWs. Based on the data recorded by VHWs, the computer algorithm identified 552 neonates with sepsis, giving an incidence of sepsis of 10.5%. Of these 552 cases of sepsis, the VHWs correctly diagnosed 492 (89.1%). The ability of the VHWs to diagnose sepsis in comparison to the computer algorithm is presented in Table 1 .
The yearly incidence of sepsis and the proportion of sepsis cases treated by VHWs is presented in Table 2 . Both the incidence of sepsis and the percent treated by VHWs increased over the first few years of the study. In the last year recorded, 93/751 infants (12.4%) were diagnosed by computer algorithm and 86 of these (92.5%) were actually treated by the VHWs.
The gestational age distribution of the 552 cases was: term (462, 83.7%) and preterm (<37 weeks; 86, 15.6%). Among preterm infants, 61 (71% of all preterm infants) were 35 to 36 weeks, nine (10.5%) were 33 to 34 weeks, and 16 (18.6%) were <32 weeks gestation. Gestation was not recorded in four (0.7%) neonates. The distribution of birth weights was: 2500 g or more, 256 (46.4%) and LBW (<2500 g) 293 (53.1%). Among LBW infants 187 (63.8% of all LBW infants) were 2000 to 2499 g; 51 (17.4%) were 1750 to 1999 g; 29 (10%) were 1500 to 1749; and 26 (9%) were <1500 g. Birth weight was not recorded for three (0.5%) newborns. Our method of diagnosing sepsis required at least two diagnostic criteria to be present simultaneously in a neonate. The clinical features present in 552 neonates with suspected sepsis are presented in Table 3 . All infants had more than two diagnostic criteria, with a mean of 3.3 criteria. The most frequently recorded signs/ symptoms were sucking reduced or stopped; grunting or chest indrawing (retraction), and cry became weak or stopped. For all infants with presumed sepsis, the age at diagnosis ranged from 1 to 28, with a mean of 11.1 days. For those who died with a diagnosis of sepsis, the mean age at the time of death was 7 days, and the mean age at diagnosis was 5.3 days. There was a relatively short time interval between sepsis diagnosis and death.
The feasibility of home-based diagnosis and treatment as evaluated is presented in Table 4 . The vast majority of infants (93.1%) were visited by VHWs. The VHWs were likely to (89.1%) accurately diagnose a case of clinical sepsis (as defined) and only missed 10.9% cases or overdiagnosed 4.2% patients (as compared to diagnosis by computer algorithm). Of the 492 patients diagnosed by the VHW to have presumed sepsis, parents agreed to and were able to hospitalize only 13 infants (2.6%), but agreed to homebased treatment for almost all infants (91.1%). Of note, in 31 cases (6.3%), parents refused both home and hospital care. Thus, the total number of neonates treated as sepsis by VHWs (true cases treated þ false positives) was 470, that is, 8.9% of the neonates in the intervention area. Home-based treatment of presumed neonatal sepsis was very effective at reducing sepsis-related deaths (Table 5 ). In the preintervention period, 16.6% of newborns with a diagnosis of clinical sepsis died. By contrast, in the post-intervention period 6.9% of those who were treated died as compared to 22% of those who were untreated (either because of missed diagnosis or parental refusal of treatment).
The effect of home-based management on the case fatality in untreated and treated neonates categorized by estimated gestational age and by birth weight is shown in Table 6 . Case fatality (CF) for both treated and untreated infants was inversely related to estimated gestational age and birth weight F that is, the risk of death decreased with increasing gestational age and birth weight. Home-based management resulted in a significant reduction in the CF for both term (62.1% reduction) and preterm infants (67.2% reduction) and for those who were under 2500 g birth weight (71.9% reduction). Of note, although home-based management resulted in a 31% reduction in the CF for infants over 2500 g birth weight, this finding was not statistically significant, probably because of the already low CF for this group without treatment. The effect of home-based management compared by age at diagnosis in those who were treated and those who were untreated (diagnosis missed or parents refused treatment) is presented in Table 7 . The younger the newborn, the higher the CF. For all age groups, CF was higher in the group who were untreated. Homebased treatment significantly reduced the risk of death for neonates with both an early (first week of life) and later diagnosis of neonatal sepsis.
VHWs gave 4793 injections of gentamicin. They also gave 5069 injections of vitamin K. To date, we have not identified any neonate with injection-related complications, including infection at the injection site, hemorrhage, nerve injury, or allergic rash. We have not maintained a record of the needle injuries to VHWs. However, the prevalence of HIV-positive Elisa test in pregnant women attending the women's clinic of SEARCH in the adjacent area was less than 0.1% during this period.
The difficulties expressed by VHWs in the review meetings or observed in supervisory visits included:
1. Not able to visit a neonate due to lack of information about its birth or arrival from outside. This was more common when mothers moved to parents' home for delivery a few days before delivery.
2. Parents not informing VHWs about development of a danger sign or symptom on a non-visit day. 3. VHW misinterpreting the clinical criteria, especially when the baby was sick from birth due to asphyxia or prematurity. 4. Natural variations in the respiratory rate in a newborn, causing difficulty in correctly counting and recording respiratory rate. 5. Despite advice from the VHWs, parents refusing to take a seriously ill neonate to hospital or refusing treatment. 6. Apprehension about the possibility of death especially when treating a preterm baby of < 32 weeks gestation, or a LBW baby <1500 g, because the treatment by VHW could be blamed for death. 7. Maintenance of oral feeding and body temperature in neonates <32 weeks or <1500 g often became difficult. 8. Parents or other families in village making request to VHW to give other medicinal injections as well.
Apart from the initial surprise and skepticism in the local medical community about a VHW treating neonatal sepsis with injection gentamicin, we did not experience any opposition. The professional leadership, including the members of the external advisory group and the national office bearers of organizations such as the IAP and NNF of India, actively engaged in discussions and decisions, and approved of this approach. The national workshops passed unanimous resolutions supporting this approach.
12,13
DISCUSSION
This analysis covering 7 years of data from the Gadchiroli trial shows that it is feasible to screen neonates in a community with 93% coverage and to identify the suspected cases of sepsis with estimated 89% sensitivity as compared to the guidelines. In many parts of the world, most births and neonatal deaths occur at home. In areas that are far from health-care facilities or when families are unable or refuse to leave their homes and villages for care, creative approaches to the delivery of health care are needed. Earlier studies in Gadchiroli suggested that trained VHWs could identify sick newborns in their homes and were able to treat neonates with presumed sepsis and pneumonia appropriately and in a timely manner, thus reducing neonatal mortality. This study extends our earlier studies, confirms the earlier findings, and presents a new evidence about feasibility, acceptance, and problems.
Infections (primarily neonatal sepsis, pneumonia, and meningitis) have been reported to be the major causes of neonatal death in many developing countries.
1,2 Untreated, neonatal infections can very quickly result in serious illness and death. They are potentially preventable causes of neonatal mortality.
In this study, VHWs used strictly defined clinical criteria to diagnose presumed sepsis in a setting where there was no laboratory to make a definitive microbiologic diagnosis. We have selected these diagnostic criteria to be able to identify all potentially fatal cases of sepsis. We acknowledge that our criteria may overdiagnose sepsis (false-positive cases). We have evaluated 14 that, using these criteria, nearly 10% neonates in rural Gadchiroli would be identified as sepsis (the yield). The ability of these trained health workers to make a diagnosis of clinical sepsis was very similar to that of a computer-based algorithm using the same criteria, confirming that it is possible to train women with limited formal education and no prior medical or nursing education to examine newborns and to decide if they are ill or not. Of note, using this computer-based comparison, VHWs missed a diagnosis of presumed sepsis in only 11% cases and only 4% of the treatment was unnecessary treatment.
The major finding of this study is that home-based treatment of presumed sepsis with intramuscular gentamicin and oral cotrimoxazole was able to markedly reduce the CF rate. While 16.6% of infants with presumed sepsis died in the pre-intervention period and 22% of those who were untreated (missed diagnosis or refused treatment) during the intervention period died, only 6.9% of those who were treated by VHWs died. Although the risk of death was greatest in neonates who were preterm and/or of low birth weight, there was a similar reduction in %CF among both term and preterm infants who were treated in the home. The preterm neonates included in this study were of 28 to 37 weeks gestation. A neonate born before 28 weeks is not considered viable in India. 15 Nearly three-fourths of the LBW neonates were full term, but intrauterine growth restricted neonates, most of them with birth weight >1500 g. Although early neonatal sepsis occurring in the first week of life had the highest CF, there was a significant reduction in CF for home-based treatment throughout the neonatal period.
A potential criticism of this approach is that diagnostic criteria are based upon nonspecific signs and symptoms that may reflect a number of pathologic neonatal conditions, in addition to sepsis (including surfactant-deficient respiratory distress of the premature infant and hypoxic-ischemic encephalopathy of the term infant). Therefore, neonatal sepsis may have been overdiagnosed in the intervention sites. However, because of the high risk of death in untreated sepsis, an accepted principle in the management of neonatal sepsis even in developed countries is to treat on the slightest suspicion of infection. Remington and Klein reported that in the neonatal nurseries in Boston, 6.5% neonates were treated with antibiotics for suspected sepsis, though of those treated only 6% turned out to be culture positive. 9 Moreover, despite possible concerns about accuracy of the diagnosis, the home-based treatment by VHWs in our study did result in a significant reduction in CF in treated cases and, as reported earlier, in the allcause NMR by 62%. 5 The importance of health education for mothers and families in the community must be emphasized. Despite recommendations by VHWs, the majority of families refused to take their neonates to hospital for care. Although families accepted home-based care, VHWs were concerned that parents did not always inform them about a sick infant on a non-visit day and thus treatment was delayed for some infants. Obviously, there is a great scope for improvement in parental-care-seeking behavior.
Although we were concerned about potential problems in allowing a VHW to give intramuscular injections to a sick neonate, including complications of injections and unnecessary or excessive use of injections, none of these occurred during the 7 years study period. This evidence suggests that, with proper training, motivation, supervision, and community education, potential hazards can be avoided.
A major concern about home-based care is whether it is ethical to allow a VHW, rather than a doctor, to diagnose and treat a potentially fatal disease such as neonatal sepsis. Ideally, all such neonates should be hospitalized, evaluated by a highly specialized medical team and treated. However, the ideal conditions do not exist in the real world. In areas where hospitals are not accessible, or where hospitals do not have facilities to care for a sick neonate or when parents cannot or do not want to hospitalize a sick neonate, not to treat a life-threatening condition may be considered unethical. Use of injections by nonphysicians has already been accepted and widely practiced in immunization programs or in situations such as self-administration of insulin by insulin-dependent diabetic patients. The risk of death and hence the urgent need to treat is greater in the case of a neonate with sepsis in a rural home.
Although the local medical community was initially skeptical about the ability of VHWs to treat sick infants with antibiotics (especially injectable antibiotics) in the home, they did not oppose the program and became great supporters once the success of the intervention was established. Furthermore, national opinion leaders and decision makers (such as the successive national presidents of the IAP and the NNF) have actively supported this innovative approach. 12, 13 The unresolved issues for further research are: (1) improving methods of family education for recognition of sick neonate and better care seeking, (2) making gentamicin available in Uniject device which can be easily administered, (3) choice of antibiotics which can be administered orally, (4) interventions to prevent early-onset sepsis because it contributes most of the remaining sepsis deaths in Gadchiroli, (5) in the cases with fatal outcome, the mean duration of treatment before death was only 1.7 day. Earlier initiation of treatment will further improve the survival.
Significance
The success of the Gadchiroli trial in reducing sepsis-related neonatal mortality in a community setting with limited resources is promising for other developing countries. This intervention is currently being adapted to other settings in India and elsewhere in the developing world. If successful in replicating the findings in Gadchiroli, these studies will have broad public health implications for the prevention of neonatal mortality in developing countries.
Such innovations are not new. The history of public health in developing countries shows similar examples wherein hospitalbased treatment of dreaded infections was simplified and substituted by home-based treatment. Domiciliary treatment of tuberculosis, oral rehydration therapy for cholera and other watery diarrhea, and community-based management of pneumonia in children are some such successful innovations. These have saved more lives than many other costly treatments. A similar change might occur in the public health approach to the management of neonatal infections in developing countries.
